Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Appian Corp (APPN) vs Bath & Body Works Inc (BBWI) Price & Performance

Appian Corp
Bath & Body Works Inc

Price performance

Price movement over the last 24 hours

Key statistics

Appian Corp vs Bath & Body Works Inc — how do they compare? Appian Corp trades at $25.44 (market cap $1.86B), while Bath & Body Works Inc trades at $20.33 (market cap $4.10B). The key difference: Bath & Body Works Inc is far larger — about 2.2× Appian Corp's market cap, and Bath & Body Works Inc pays a 3.94% dividend while Appian Corp pays none. Which is the better fit depends on your goals.

APPNBBWI
Market Cap
$1.86B$4.10B
Sector
TechnologyConsumer Cyclical
52-Week High
$45.64$33.11
52-Week Low
$18.72$14.85
Enterprise Value
$1.95B$7.99B
Dividend Yield
3.94%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Appian Corp

Appian (APPN) trades at $25.36, up 0.48% on the day, with a bullish technical signal from moving averages and a consensus price target of $26.20. The company reported positive net income in 2025 after years of losses, with revenue growing to $726.94M and operating cash flow improving to $62.87M. Recent news highlights focus on AI strategy and enterprise adoption, though the CEO's share sale and negative shareholder equity present mixed signals.

The outlook is cautiously optimistic with revenue growth and cash flow recovery, but risks include high debt levels, negative equity, and intense competition. Analyst sentiment is mixed with a majority Hold rating. The stock offers potential from AI-driven growth but requires monitoring of profitability sustainability and balance sheet health.

Bath & Body Works Inc

BBWI trades at $20.33, up 2.01% today, with a bearish technical signal but neutral oscillators. The stock shows strong profitability with a net margin of 10.03% and attractive valuation ratios, including a P/E of 5.78. Recent earnings beat expectations in Q1 2026, and the company's partnership with Ulta Beauty aims to expand reach. Cash flow trends indicate improving net cash flow by 2026, though the balance sheet carries significant debt.

The outlook is mixed: analyst consensus is a Buy with a $22.00 price target, suggesting upside, but risks include declining revenue over five years and high leverage. The Ulta partnership and cost-saving initiatives offer growth potential, yet competitive pressures and macroeconomic headwinds pose challenges for sustained performance.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Appian Corp

Appian Corp provides a low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications. With its platform, organizations can rapidly and easily design, build and implement powerful, enterprise-grade custom applications through intuitive, visual interface with little or no coding required. The company's customers use applications built on its low-code platform to launch new business lines, automate vital employee workflows, manage complex trading platforms, accelerate drug development and build procurement systems. The group generates a majority of its revenue from the domestic market. It serves various industries such as education.

Read more on APPN

About Bath & Body Works Inc

Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.

Read more on BBWI